Related Experiment Video
Updated: Jun 14, 2026
06:08
A Novel Method: Super-selective Adrenal Venous Sampling
Published on: September 15, 2017
Polymorphisms in CYP11B2 and CYP11B1 genes associated with primary hyperaldosteronism
Guo-xi Zhang1, Bao-jun Wang, Jin-zhi Ouyang
1Department of Urology, Clinical Division of Surgery, Chinese PLA General Hospital, Beijing, PR China.
Summary
Genetic variations in CYP11B2 and CYP11B1 genes are linked to primary hyperaldosteronism (PH). Specific gene polymorphisms and haplotypes show significant associations with aldosterone-producing adenoma (APA) and idiopathic hyperaldosteronism (IHA) risk.
Area of Science:
- Endocrinology and Genetics
- Molecular Biology
- Hypertension Research
Background:
- Essential hypertension is often linked to aldosterone secretion.
- Polymorphisms in the CYP11B2 gene are implicated in aldosterone production.
- The genetic basis of primary hyperaldosteronism (PH) requires further investigation.
Purpose of the Study:
- To investigate the association between polymorphisms in CYP11B2 and CYP11B1 genes and the risk of primary hyperaldosteronism (PH).
- To identify specific genetic markers associated with aldosterone-producing adenoma (APA) and idiopathic hyperaldosteronism (IHA).
Main Methods:
- Analysis of three CYP11B2 gene polymorphisms (intron 2 conversion, rs1799998, rs4539) and two CYP11B1 gene polymorphisms (rs6410, rs6387).
- Genotyping was performed in patients with PH (APA and IHA) and a control population.
- Statistical analysis included allelic and genotypic frequency comparisons, haplotype analysis, and odds ratio calculations with confidence intervals.
Main Results:
- Significant differences in rs6410 allelic frequencies were observed between PH subtypes and controls (P=1.09 x 10(-5) for APA, P=0.015 for IHA).
- Specific genotypes (AA, AG) of rs6410 were associated with APA and IHA, with notable odds ratios after adjustments for IHA.
- Several susceptible haplotypes (AAAWT, AGGWT, AGAWC) were linked to APA and IHA, while a protective haplotype (GGAWT) was identified for APA.
Conclusions:
- Polymorphisms in CYP11B2 and CYP11B1 genes are significantly associated with a genetic predisposition to primary hyperaldosteronism.
- The genetic association with idiopathic hyperaldosteronism (IHA) appears stronger than with aldosterone-producing adenoma (APA).
- These findings contribute to understanding the genetic underpinnings of PH and may aid in risk stratification.
Related Concept Videos
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:28Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:27Adrenal Gland Disorders
Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
01:16Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...